Hercules Capital, Inc. (HTGC) Stock Price & How to Invest

Hercules Capital is a business development company (BDC) that provides senior secured, mostly first-lien loans to venture-capital-backed companies in technology and life sciences. It is recognized as the largest non-bank venture lender, having committed more than $27 billion to over 700 companies since inception, with over $6 billion in assets under management. Roughly 90% of its portfolio is senior secured and floating-rate, with portfolio yields averaging near 13.9%, and individual loans typically sized around $20 million to $40 million. As a BDC, Hercules must distribute most of its taxable income, which is why the stock is held primarily for income.

The investment picture centers on yield, credit quality, and rate sensitivity. Because loans float, income rose sharply as benchmark rates climbed, and Hercules has posted record commitments and rising investment income into 2026, with total investment income reaching ~$149.1 million in the second quarter. The counterweights are that falling rates would compress the yield, its borrowers are often young and unprofitable companies whose credit can deteriorate in a downturn, and the shares frequently trade at a meaningful premium to net asset value, which raises the bar for new capital. Nonaccruals have stayed low, and dividend coverage has been strong, but the model concentrates risk in the venture ecosystem.

The stock has lagged that income. Hercules closed at $16.54 on October 16, 2026, down ~12.3% year to date and ~3.6% over twelve months, for a market value of about $3.1 billion and a price-to-book ratio near 1.34x on Yahoo Finance data. Second-quarter net investment income of ~$0.50 per share beat the ~$0.48 consensus. In October the company closed an upsized $400 million offering of 6.700% notes due 2029, and Fitch affirmed its BBB- investment-grade rating on October 16. Third-quarter results are due October 29, 2026, with consensus NII of ~$0.48 per share.

Hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. Because roughly 90% of the book is floating-rate, falling benchmark interest rates would compress portfolio yields and pressure net investment income and the dividend. The shares have often traded at a large premium to net asset value (a price-to-book ratio near 1.34x in October 2026 on Yahoo data, down from a premium of over 70% in 2024), which adds valuation risk if the premium compresses. Operating expenses rose sharply year over year, and like all BDCs, Hercules relies on continued access to debt and equity markets to fund portfolio growth. Net asset value per share slipped to about $11.90 at March 31, 2026, from $12.13 at year-end 2025. Consensus expects NII per share to be roughly flat, ~$1.93 for 2026 and ~$1.97 for 2027, against an indicated dividend of ~$1.88, so coverage is adequate but leaves little room, and new 6.700% notes cost more than some of the debt they add to.

9 analysts publish price targets on HTGC, averaging $19.50 against a $16.37 price as of October 2026, or +19.1%. The published targets run from $17.00 to $25.00, a moderate spread, and the ratings split 8 buy, 1 hold, 0 sell. Over the last six months there have been 3 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full HTGC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Hercules Capital, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Record originations and portfolio growth. Hercules set an all-time high in new debt and equity commitments of roughly $1.81 billion in Q1 2026, and net debt portfolio growth of about $298 million pushed total investment income to a record near $141.5 million. The most optimistic published target, $25.00, assumes this works close to its best case.

The case against. Hercules lends to high-growth, frequently unprofitable venture-backed companies, so a weak venture funding environment or recession could drive rising nonaccruals and net asset value markdowns. The most pessimistic target, $17.00, is roughly what HTGC is worth if this bites instead.

Read the full bull and bear case on HTGC, including what would have to change to break either one. Walnut is not an investment adviser.

No. Hercules Capital, Inc. (HTGC) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Hercules Capital, Inc.'s investor relations page or your broker.

• Total investment income (TTM): ~$566M; Q2 2026 ~$149.1M, up ~8.5% year over year
• Net investment income (Q2 2026): ~$0.50/share vs ~$0.48 consensus
• Net income (TTM): ~$380M; P/E ~8.2x trailing, ~8.4x forward
• Net asset value per share: ~$11.90 (Mar 31 2026); price-to-book ~1.34x (Oct 2026)
• Market cap: ~$3.1B at $16.54 (Oct 16, 2026)
• Dividend yield: ~11.3% on a $1.88 indicated annual rate
• Debt: ~$2.35B; BBB- affirmed by Fitch Oct 2026

Hercules earned ~$2.01 per share over the trailing twelve months and consensus looks for ~$1.93 in 2026, so at $16.54 the stock trades near 8 times earnings with an ~11.3% yield. The shares sit ~12% lower than at the start of 2026, at a price-to-book ratio near 1.34x, narrower than the 70%-plus premium of 2024. The high yield reflects both the floating-rate portfolio and the market's pricing of venture-credit risk and lower benchmark rates.

Other names that sit close to HTGC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get HTGC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so HTGC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where HTGC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Hercules is a scaled, well-covered venture-debt BDC offering a large yield, with the trade-off being exposure to venture credit cycles, falling benchmark rates, and a share price that often trades at a premium to net asset value. The shares are down ~12% in 2026 even as net investment income has held at roughly $0.48 to $0.50 a quarter, and Q3 results arrive October 29.

Whether HTGC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HTGC a buy or a sell?, and where the stock could go from here in the HTGC stock forecast.

For income investors, whether HTGC pays a dividend and how the payout looks is covered in does HTGC pay a dividend? And to weigh HTGC against a peer, read the full side-by-side comparisons: HTGC vs TRN and HTGC vs ARCC.